Top 10 Information Technology Stocks To Watch For 2015

Top 10 Information Technology Stocks To Watch For 2015: Incyte Corporation(INCY)

Incyte Corporation focuses on the discovery and development of proprietary small molecule drugs for hematologic and oncology indications, and inflammatory and autoimmune diseases. Its product pipe line includes INCB18424, which is in Phase III clinical trial for myelofibrosis; Phase III trial for polycythemia vera; Phase III trial for essential thrombocythemia; Phase I/II trial to treat solid tumors/other hematologic malignancies; and Phase IIb trail for the treatment of psoriasis. The company?s portfolio also includes INCB28050, a Phase IIb clinical trial product for rheumatoid arthritis; INCB28060, a Phase I/II product for solid tumors; INCB7839, a Phase II product for breast cancer; and INCB24360, a Phase I/II product for solid tumors. It has a collaborative research and license agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; and Pfizer Inc. The company was founded in 1991 and is headquartered in Wilmington, Delaware.

Advisors' Opinion:

• [By Maxx Chatsko]

  Pfizer will turn its immediate focus to Xeljanz, a novel JAK3 inhibitor, as it awaits phase 3 data from ertugliflozin several years from now. The drug class has swept the pharmaceutical industry by storm. Novartis (NYSE: NVS  ) and Eli Lilly are developing JAK1 and JAK2 inhibitors for several applications with Incyte (NASDAQ: INCY  ) , while a handful of other companies have molecules of their own. While companies have high hopes for the cancer-fighting potential of JAK inhibitors, such as Jakafi from Novartis and Incyte, the biggest opportunities may lie in the immunology market.

• [By John McCamant]

  Incyte Pharmaceuticals (INCY) recently held their quarterly conference call. Importantly, sales for Jakafian advanced compound used for the treatment of patients with intermediate or high-risk myelofibrosis (MF)met or exceeded Wall Street's expecta! tions.

• [By Jim Jubak]

  But a bigger reason to sell, in my opinion, right now, is a change in the risk/reward profile of the market as a whole. The recent sell off in momentum stockswhich now looks like it's spreading to consumer discretionary leadersmakes me want to raise cash for the inevitable bounce back in these stocks. I don't know when we might see that bounceand I'm not buying yet, since I think we're still in catch a falling knife territory. But when stocks such as FireEye (FEYE), or Palo Alto Networks (PANW), or Incyte (INCY), or Chipotle Mexican Grill (CMG) do bounce, the gains will be bigger and quicker than those in holding Citigroup.

source from Top Penny Stocks For 2015:http://www.topstocksforum.com/top-10-information-technology-stocks-to-watch-for-2015.html